World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
70
Citations
18834
World Ranking
2270
National Ranking
77

Mathieu Lupien publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Mathieu Lupien sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 192 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Mathieu Lupien D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Mathieu Lupien sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 70 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Mathieu Lupien is a researcher affiliated with the Princess Margaret Cancer Centre in Canada. Their work primarily spans biochemistry, genetics, and molecular biology, with a significant focus on medicine. Lupien's research delves into various subfields including molecular biology, cancer research, pulmonary and respiratory medicine, hematology, and genetics.

Lupien's research themes center around several key topics in biomedical science. These include genomics and chromatin dynamics, cancer genomics and diagnostics, epigenetics and DNA methylation, RNA modifications in cancer, prostate cancer treatment and research, glioma diagnosis and treatment, and cancer-related gene regulation.

They have contributed to multiple publications in well-known venues. The most frequent publication outlets are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Cancer Research
  • Nature Genetics
  • Cell Stem Cell

The scientist has co-authored extensively with several researchers, including Christopher Arlidge, Stanley Zhou, Alex Murison, John E. Dick, and C.H. Arrowsmith.

Some of Lupien's recent papers include the following notable works:

  • Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity, 2021, Nature Cancer
  • GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer, 2020, Nature Communications
  • PRMT5 inhibition disrupts splicing and stemness in glioblastoma, 2021, Nature Communications
  • Pioneer of prostate cancer: past, present and the future of FOXA1, 2020, Protein & Cell
  • Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer, 2020, Cancer Discovery

Their work reflects a focused interest in understanding cancer mechanisms at the molecular and epigenetic levels, with a particular emphasis on cancer types such as glioblastoma, breast cancer, and prostate cancer. The research involves examining regulatory pathways, transcriptional states, and genomic alterations that contribute to cancer progression and treatment resistance.

Best Publications

  • FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription

    Mathieu Lupien;Jérôme Eeckhoute;Clifford A. Meyer;Qianben Wang

  • Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

    Qianben Wang;Wei Li;Yong Zhang;Xin Yuan

  • Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

    S. C. Mack;H. Witt;R. M. Piro;L. Gu

  • Genomic hallmarks of localized, non-indolent prostate cancer

    Michael Fraser;Veronica Y. Sabelnykova;Takafumi N. Yamaguchi;Lawrence E. Heisler

  • Nucleosome dynamics define transcriptional enhancers.

    Housheng Hansen He;Clifford A. Meyer;Hyunjin Shin;Shannon T. Bailey

  • Positive Cross-Regulatory Loop Ties GATA-3 to Estrogen Receptor α Expression in Breast Cancer

    Jérôme Eeckhoute;Erika Krasnickas Keeton;Mathieu Lupien;Susan A. Krum

  • Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer

    Sunita R. Setlur;Kirsten D. Mertz;Yujin Hoshida;Yujin Hoshida;Francesca Demichelis

  • Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy

    Xiaoyang Lan;David J. Jörg;Florence M. G. Cavalli;Laura M. Richards;Laura M. Richards

  • Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.

    Olivia Corradin;Alina Saiakhova;Batool Akhtar-Zaidi;Lois Myeroff

  • Epigenomic enhancer profiling defines a signature of colon cancer

    Batool Akhtar-Zaidi;Batool Akhtar-Zaidi;Richard Cowper-Sal·lari;Olivia Corradin;Alina Saiakhova

  • Breast cancer risk–associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression

    Richard Cowper-Sal·lari;Xiaoyang Zhang;Jason B Wright;Swneke D Bailey;Swneke D Bailey

  • A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.

    Carsten Bahr;Carsten Bahr;Lisa von Paleske;Lisa von Paleske;Veli V. Uslu;Silvia Remeseiro

  • Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19

    Junjie Tony Hua;Junjie Tony Hua;Musaddeque Ahmed;Haiyang Guo;Yuzhe Zhang;Yuzhe Zhang;Yuzhe Zhang

  • Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer

    David Brocks;Yassen Assenov;Sarah Minner;Olga Bogatyrova

  • Functional Enhancers Shape Extrachromosomal Oncogene Amplifications

    Andrew R. Morton;Nergiz Dogan-Artun;Zachary J. Faber;Graham MacLeod

  • PharmacoGx: an R package for analysis of large pharmacogenomic datasets

    Petr Smirnov;Zhaleh Safikhani;Nehme El-Hachem;Dong Wang

  • Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers

    Aurélien A. Sérandour;Stéphane Avner;Frédéric Percevault;Florence Demay

  • CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.

    Seth Frietze;Mathieu Lupien;Pamela A. Silver;Myles Brown

  • Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors.

    Chunyan Hu;Anne Diévart;Mathieu Lupien;Ezequiel Calvo

  • Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

    Jonathon Torchia;Brian Golbourn;Shengrui Feng;Shengrui Feng;King Ching Ho

Frequent Co-Authors

Cheryl H. Arrowsmith
Cheryl H. Arrowsmith Structural Genomics Consortium
Benjamin Haibe-Kains
Benjamin Haibe-Kains Princess Margaret Cancer Centre
John E. Dick
John E. Dick Princess Margaret Cancer Centre
Myles Brown
Myles Brown Harvard University
Paul C. Boutros
Paul C. Boutros University of California, Los Angeles
Trevor J. Pugh
Trevor J. Pugh Princess Margaret Cancer Centre
Housheng Hansen He
Housheng Hansen He University of Toronto
Peter B. Dirks
Peter B. Dirks University of Toronto
Robert G. Bristow
Robert G. Bristow University of Manchester
Michael D. Taylor
Michael D. Taylor University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in Genetics but considering alternative or complementary career paths? The rise of flexible online education means you can explore related healthcare and science careers from anywhere.

For example, those seeking fast entry into the healthcare field may consider specialized programs such as the best online medical billing and coding schools. This path offers strong job growth and can be completed entirely online.

If your goal is to earn a degree more quickly, look into programs offered by fast track schools. These accelerated options help you launch your career sooner, whether your interest is in health sciences, biology, or related fields.

Flexible learners may benefit from self paced college courses, which allow you to set your own study schedule. This is ideal for those balancing work, family, or other commitments.

Finally, if application fees are a concern, consider exploring online schools no application fee. These programs can help reduce upfront costs as you start your educational journey in genetics or allied areas.

Best Scientists Citing Mathieu Lupien

Trending Scientists

Recently Published Articles